Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Front Immunol. 2020 Nov 30;11:615056. doi: 10.3389/fimmu.2020.615056. eCollection 2020.
The intestinal microbiota, composed of a large population of microorganisms, is often considered a "forgotten organ" in human health and diseases. Increasing evidence indicates that dysbiosis of the intestinal microbiota is closely related to colorectal cancer (CRC). The roles for intestinal microorganisms that initiated and facilitated the CRC process are becoming increasingly clear. Hypothesis models have been proposed to illustrate the complex relationship between the intestinal microbiota and CRC. Recent studies have identified , enterotoxigenic , , , , and as CRC candidate pathogens. In this review, we summarized the mechanisms involved in microbiota-related colorectal carcinogenesis, including inflammation, pathogenic bacteria, and their virulence factors, genotoxins, oxidative stress, bacterial metabolites, and biofilm. We also described the clinical values of intestinal microbiota and novel strategies for preventing and treating CRC.
肠道微生物群由大量微生物组成,通常被认为是人类健康和疾病中的“被遗忘的器官”。越来越多的证据表明,肠道微生物群的失调与结直肠癌(CRC)密切相关。肠道微生物在启动和促进 CRC 过程中的作用正变得越来越清晰。已经提出了假设模型来阐明肠道微生物群与 CRC 之间的复杂关系。最近的研究已经确定了产肠毒素、、、、和 作为 CRC 的候选病原体。在这篇综述中,我们总结了与肠道微生物群相关的结直肠发生致癌作用的机制,包括炎症、致病菌及其毒力因子、遗传毒素、氧化应激、细菌代谢物和生物膜。我们还描述了肠道微生物群的临床价值和预防及治疗 CRC 的新策略。